However, in the Royal Marsden trial, women on both tamoxifen and HT were less likely to develop ER-positive tumors (3.6 per 1,000 women on tamoxifen had ER-positive tumors per year v 7.9 per 1,000 in ...

Tamoxifen was also effective against the parasite in vivo, as shown in various experimental rodent models of visceral and cutaneous leishmaniasis. In all models tested, parasite burden and/or lesion ...